SLC7A11 and cancer: The mechanism of SLC7A11 in therapeutic resistance involves the antioxidant stress system, ferroptosis, nutrient limitation, autophagy, multidrug resistance, etc. Microarray analysis of the gene expression of transporter proteins in 60 human cancer cells showed that SLC7A11 expression was correlated with the efficacy of 1400 candidate anticancer drugs [151].